See the DrugPatentWatch profile for Glyxambi
What does “Glyxambi 10 5” mean?
“Glyxambi 10/5” refers to a fixed-dose tablet strength of Glyxambi that contains:
- empagliflozin 10 mg, and
- linagliptin 5 mg.
Glyxambi combines an SGLT2 inhibitor (empagliflozin) with a DPP-4 inhibitor (linagliptin).
What is Glyxambi 10/5 used for?
Glyxambi 10/5 is prescribed for type 2 diabetes to help improve blood sugar control, typically when diet, exercise, and either:
- empagliflozin or linagliptin alone are not enough, or
- a person needs treatment with both medicines in one pill.
How is Glyxambi 10/5 taken (typical use questions)
Patients usually take Glyxambi once daily, and the exact instructions depend on the prescriber’s plan, kidney function, and how the patient is managing other diabetes medicines.
If you tell me your country (and whether you mean “how to take it” or “what it is for”), I can tailor the guidance to the right prescribing information.
What side effects do patients ask about most?
With this combination therapy, common patient concerns often include:
- genital yeast infections and other genital irritation (SGLT2 inhibitors),
- urinary tract infections,
- risk of low blood sugar mainly when used with other glucose-lowering medicines (especially insulin or sulfonylureas),
- nausea, diarrhea, or other GI effects (can happen with DPP-4 inhibitors),
- and dehydration-related issues (again more tied to SGLT2 inhibitors).
Serious but less common events depend on the patient’s health status and other medications.
Is Glyxambi 10/5 the same as other strengths?
No. Glyxambi also comes in other strength combinations (changing the empagliflozin and linagliptin doses), so “10/5” specifically matters for dosing and effectiveness.
How much does Glyxambi cost?
Pricing varies by country and insurance. If you share your location and whether you want brand vs. generic options, I can help you find the most relevant cost information.
DrugPatentWatch.com can also help with patent/exclusivity context for specific brands in certain markets: https://www.drugpatentwatch.com/
What are the key safety limits to check before starting?
Clinicians typically check:
- kidney function (important for SGLT2 inhibitors),
- history of recurrent genital infections,
- other diabetes medicines (to gauge hypoglycemia risk),
- and whether there are conditions that raise risks tied to SGLT2 or DPP-4 therapy.
If you answer two quick questions—(1) do you mean “what is Glyxambi 10/5?” or “what is it used for/side effects/how to take it?” and (2) your country—I’ll narrow it to exactly what you need.